Evaluation of the impact of a self-stigma reduction programme on psychosocial outcomes among people with schizophrenia spectrum disorder

J Ment Health. 2022 Feb;31(1):83-91. doi: 10.1080/09638237.2021.1922628. Epub 2021 Sep 14.

Abstract

Background: Self stigma is assumed to be more prominent in Jordanian society than in Western countries, reflecting a poor understanding of mental illness, collectivistic culture, and delay in accessing psychiatric care.

Aim: The purpose of the study is to evaluate the effectiveness of a self-stigma reduction programme on self-stigma.

Methods: A randomized controlled trial was conducted from November 2017 to December 2018 with 278 people diagnosed with schizophrenia (PDwS). Participants were randomly assigned to receive a self-stigma reduction programme (psychoeducation, cognitive behavioural therapy and social skills training), or treatment as usual (TAU).

Results: PDwS in the intervention group experienced a greater reduction in the level of self-stigma (20.19 vs -0.62; p < 0.001) at post-intervention and (37.35 vs -0.66; p < 0.001) at six-month follow-up.

Conclusions: The findings suggest that the self-stigma reduction programme has the potential to reduce self-stigma levels.

Trial registration: NCT04087954.

Keywords: Self-Stigma; psychiatric symptoms; psychosocial intervention; self-esteem.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Cognitive Behavioral Therapy*
  • Humans
  • Psychotherapy
  • Schizophrenia* / therapy
  • Social Stigma

Associated data

  • ClinicalTrials.gov/NCT04087954